Lactoferrin Alleviates Lipopolysaccharide-Induced Infantile Intestinal Immune Barrier Damage by Regulating an ELAVL1-Related Signaling Pathway

Lactoferrin Alleviates Lipopolysaccharide-Induced Infantile Intestinal Immune Barrier Damage by Regulating an ELAVL1-Related Signaling Pathway

As the most important intestinal mucosal barrier of the main body, the innate immune barrier in intestinal tract plays especially pivotal roles in the overall health conditions of infants and young children; therefore, how to strengthen the innate immune barrier is pivotal. A variety of bioactivitie...

Full description

Bibliographic Details
Main Authors: Chaonan Li, Xinkui Liu, Zhihong Huang, Yiyan Zhai, Huiying Li, Jiarui Wu
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
lactoferrin (LF)
lipopolysaccharide (LPS)
intestinal immune barrier damage
blood immune cells
ELAVL1
Online Access:https://www.mdpi.com/1422-0067/23/22/13719

Internet

https://www.mdpi.com/1422-0067/23/22/13719

Similar Items